A trio of nephrology experts discuss the significance of iptacopan’s FDA approval as the first treatment for C3G.
Jared Hassler, MD
Advertisement
Jared Hassler, MD, is a pathologist at the Temple University Hospital.
Articles by Jared Hassler, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Insulin Icodec Now Available for Type 2 Diabetes in US
2
Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes
3
Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD
4
Lonafarnib NDA Enters FDA Review for Chronic Hepatitis D
5